|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 16 January 2007
doi: 10.1242/jcs.03348
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line

1 Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, M638a Houston, TX 77030-3498, USA
2 Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Author for correspondence (e-mail: jrosen{at}bcm.edu)
Accepted 15 November 2006
The COMMA-D
-geo cell line has been shown to contain a permanent subpopulation of progenitor cells that are enriched in outgrowth potential. Using the COMMA-D
-geo cell line as a model, we sought to study the radioresistance of mammary progenitor cells. Using the putative progenitor cell marker stem cell antigen 1 (Sca1), we were able to isolate a discrete subpopulation of Sca1+ multipotent cells from the immortalized COMMA-D
-geo murine mammary cell line. At a clinically relevant dose, the Sca1+ cells were resistant to radiation (2 Gy). Sca1+ cells contained fewer
-H2AX+ DNA damage foci following irradiation, displayed higher levels of endogenous
-catenin, and selectively upregulated survivin after radiation. Expression of active
-catenin enhanced self-renewal preferentially in the Sca1+ cells, whereas suppressing
-catenin with a dominant negative,
-engrailed, decreased self-renewal of the Sca1+ cells. Understanding the radioresistance of progenitor cells may be an important factor in improving the treatment of cancer. The COMMA-D
-geo cell line may provide a useful model to study the signaling pathways that control mammary progenitor cell regulation.
Key words:
-catenin, Mammary gland, Stem, Progenitor, Cell line, COMMA-D,
-geo, Sca1
Related articles in JCS:
This article has been cited by other articles:
![]() |
C. J. Lee, J. Dosch, and D. M. Simeone Pancreatic Cancer Stem Cells J. Clin. Oncol., June 10, 2008; 26(17): 2806 - 2812. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Eyler and J. N. Rich Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis J. Clin. Oncol., June 10, 2008; 26(17): 2839 - 2845. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumaraswamy, P. Chinnaiyan, U. T. Shankavaram, X. Lu, K. Camphausen, and P. J. Tofilon Radiation-Induced Gene Translation Profiles Reveal Tumor Type and Cancer-Specific Components Cancer Res., May 15, 2008; 68(10): 3819 - 3826. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ibarra, Y. Erlich, S. K. Muthuswamy, R. Sachidanandam, and G. J. Hannon A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells Genes & Dev., December 15, 2007; 21(24): 3238 - 3243. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Rich Cancer Stem Cells in Radiation Resistance Cancer Res., October 1, 2007; 67(19): 8980 - 8984. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Moraes, X. Zhang, N. Harrington, J. Y. Fung, M.-F. Wu, S. G. Hilsenbeck, D. C. Allred, and M. T. Lewis Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia Development, March 15, 2007; 134(6): 1231 - 1242. [Abstract] [Full Text] [PDF] |
||||